At a glance
- Originator Nippon Kayaku
- Class Antineoplastics; Lignans; Tetrahydronaphthalenes
- Mechanism of Action DNA inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer; Solid tumours